Navigation Links
Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association
Date:1/28/2011

FAIRFIELD, N.J., Jan. 28, 2011 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) announced that its 2011 "Woman of the Year" is Freda Lewis-Hall, MD, chief medical officer of Pfizer. In her distinguished 30-year career, Dr. Lewis-Hall has held leadership roles in direct patient care, academics, media, government, pharmaceuticals and biotechnology.

(Photo: http://photos.prnewswire.com/prnh/20110128/DC38263)

"I am deeply honored to be named Woman of the Year by the Healthcare Businesswomen's Association," said Dr. Lewis-Hall. "HBA has been an agent of positive growth for many women who have made great contributions to the advancement of healthcare. To have been nominated for this award by my fellow members of the healthcare community is especially meaningful to me. Whether we're in industry, academia, government, or the non-profit arena, we share a common goal: to improve the quality of healthcare for all patients."

Dr. Lewis-Hall will be honored at the HBA's 22nd annual "Woman of the Year" Luncheon on Thursday, May 5, at the Hilton New York. This is the event of the year for the healthcare community, attended by nearly 2,500 leaders in the industry. Awards for Honorable Mentor, the Star Volunteer, and a group of some 100 "Rising Stars," noted for their accomplishments and contributions to the healthcare industry, will also be presented at the luncheon.

"The Healthcare Businesswomen's Association is extremely proud to honor Freda Lewis-Hall as our 2011 Woman of the Year," says Deborah Coogan Seltzer, president of the HBA and life sciences practice member at Spencer Stuart. "Dr. Lewis-Hall sets the tone for all of us with her unique abilities as a talented physician and leader. She has a longstanding commitment to the social responsibilities of healthcare leadership – especially in making sure that people have the education and understanding to make the best healthcare decisions."

"Freda defines what it means to be a leader in today's rapidly changing healthcare industry. She has a genuine and singular passion to improve the lives of patients – a passion that motivates and energizes her colleagues at Pfizer and everyone with whom she interacts. She has been a dedicated mentor and an inspiring role model to hundreds of women and men in industry, academia and medical practice," said Ian Read, CEO and president of Pfizer. "Freda is intensely engaged in critical policy dialog in the interest of better patient outcomes. We are fortunate to have her as our top physician ensuring the quality, safety and effective use of Pfizer medicines."

In September 2010, Dr. Lewis-Hall was appointed by the Government Accountability Office of the United States to the inaugural Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI). Established through the healthcare reform law, PCORI will prioritize and direct a range of research programs to improve the nation's quality of healthcare.

In 2009, Dr. Lewis-Hall was one of 15 women spotlighted by ForbesWoman as a role model for young women in science. She was recognized in 2010 as one of the 25 Most Influential African-Americans in Healthcare by Black Health magazine and as one of the 75 Most Powerful Women in Business by Black Enterprise magazine. Over the course of her career, Dr. Lewis-Hall has personally mentored more than 100 women.

Dr. Lewis-Hall has a strong record of patient advocacy, and she has spoken extensively on the impact of mental illnesses on patients, families and communities. She is a vocal champion of the imperatives to break down cultural barriers and eliminate healthcare disparities, often working closely with members of the Health Brain Trust of the Congressional Black Caucus.

Dr. Lewis-Hall earned her undergraduate degree from The Johns Hopkins University and her medical doctorate from Howard University College of Medicine. She is a Fellow of the American Psychiatric Association and serves on a number of boards, including the Society for the Advancement of Women's Health Research, the Foundation of the National Institutes of Health, and the Board of Fellows of Harvard Medical School.

The 2011 HBA nominating committee overwhelmingly agreed that Dr. Lewis-Hall's many accomplishments demonstrate her fulfillment of the criteria for Woman of the Year, including success in the healthcare industry, strong leadership capabilities, proven mentoring skills, dedication, a commitment to giving back to women, and contributions to the community. Letters of nomination were received for Dr. Lewis-Hall from across the healthcare spectrum, including public sector leaders.

About The HBA

The Healthcare Businesswomen's Association (HBA; http://www.hbanet.org) is in its fourth decade as a global not-for-profit organization dedicated to furthering the advancement of women in healthcare worldwide. With 15 chapters and affiliates throughout the US and in Europe, the HBA is headquartered in New Jersey with offices in Philadelphia and Research Triangle Park. The HBA provides educational opportunities for women and men to develop cutting-edge healthcare industry knowledge and leadership skills; recognizes outstanding women and men in the industry; provides opportunities for networking; creates greater visibility for women in the industry; fosters mentoring relationships and serves as a conduit and sponsor for research on career advancement issues. The HBA has over 6,000 individual members and 120 Corporate Partners. It is widely recognized as the catalyst for leadership development of women in healthcare worldwide. For more information, visit www.hbanet.org.


'/>"/>
SOURCE Healthcare Businesswomen's Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of ... announced today its plans to open a flagship location in Covington, LA at 401 ... Rooms To Go store next to Office Depot in the Holiday Square shopping center. ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):